Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Shanghai Kehua Acquires Italian IVD Maker in $31.5 Million Deal

publication date: Dec 21, 2015
KHB Shanghai Kehua Bio-Engineering, a major China IVD company, paid $31.5 million to acquire Technologenetics of Italy, also an IVD developer. The acquired assets of Technologenetics were put into a Joint Venture, 80% owned by Kehua and the remaining 20% by another IVD company, Altergon Italia. Altergon will contribute its R&D site in Southern Italy and also its facilities in China (Qingdao and Shenzhen) for its share. Kenua's $31.5 million investment consists of $20.5 million for the acquisition and another $11 million to be invested in the JV over the next 18 months. More details....

Stock Symbol: (SHZ: 2022)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital